MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 25mg tablets (Advanz Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 25mg tablets (Advanz Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nortriptyline 50mg tablets (Advanz Pharma).

Stability Notes

Protect from light, store in airtight containers and protect from moisture. Max 14 days in MCA.

Provenance

This compatibility recommendation is derived from Norvir 100mg tablets (AbbVie Ltd).

Stability Notes

No special storage conditions.

Provenance

This compatibility recommendation is derived from Noxafil 100mg gastro-resistant tablets (Merck Sharp & Dohme (UK) Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Nozinan 25mg tablets (Sanofi).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.